Sulfamethoxypyridazine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB13773 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 77 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | gout | KG + DL |
| 2 | allergic asthma | KG + DL |
| 3 | diabetic nephropathy | KG + DL |
| 4 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 5 | intrinsic asthma | KG + DL |
| 6 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 7 | Raynaud disease | KG + DL |
| 8 | type 1 diabetes mellitus | KG + DL |
| 9 | bronchitis | KG + DL |
| 10 | chronic kidney disease | KG + DL |
| 11 | congestive heart failure | KG + DL |
| 12 | autoimmune oophoritis | KG + DL |
| 13 | osteoarthritis | KG + DL |
| 14 | end stage renal failure | KG + DL |
| 15 | Prinzmetal angina | KG + DL |
| 16 | osteoarthritis susceptibility | KG + DL |
| 17 | acute pulmonary heart disease | KG + DL |
| 18 | exostosis | KG + DL |
| 19 | myocardial infarction | KG + DL |
| 20 | asthma | KG + DL |
| 21 | asthma-related traits, susceptibility to | KG + DL |
| 22 | posteroinferior myocardial infarction | KG + DL |
| 23 | posterolateral myocardial infarction | KG + DL |
| 24 | myositis fibrosa | KG + DL |
| 25 | idiopathic granulomatous myositis | KG + DL |
| 26 | septal myocardial infarction | KG + DL |
| 27 | hemoglobinopathy | KG + DL |
| 28 | pseudoachondroplasia | KG + DL |
| 29 | tendinitis | KG + DL |
| 30 | chronic renal failure syndrome | KG + DL |
| 31 | high output heart failure | KG + DL |
| 32 | acromesomelic dysplasia, Hunter-Thompson type | KG + DL |
| 33 | fibromyalgia | KG + DL |
| 34 | disorder of O-xylosylglycan synthesis | KG + DL |
| 35 | symptomatic heart failure | KG + DL |
| 36 | brachyolmia | KG + DL |
| 37 | Lesch-Nyhan syndrome | KG + DL |
| 38 | chronic pulmonary heart disease | KG + DL |
| 39 | partial deletion of the short arm of chromosome 16 | KG + DL |
| 40 | inclusion body myositis | KG + DL |
| 41 | beta-thalassemia with other manifestations | KG + DL |
| 42 | brachyolmia-amelogenesis imperfecta syndrome | KG + DL |
| 43 | arthropathy | KG + DL |
| 44 | myosclerosis | KG + DL |
| 45 | diabetes mellitus (disease) | KG + DL |
| 46 | pyropoikilocytosis, hereditary | KG + DL |
| 47 | pyruvate kinase deficiency of red cells | KG + DL |
| 48 | obsolete hyperuricemia (disease) | KG + DL |
| 49 | exostoses, multiple, | KG + DL |
| 50 | heart failure | KG + DL |
(Showing top 50 of 77 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.